The open angle glaucoma market is expected to grow at a significant CAGR during the forecast period. Glaucoma is an optical illness that can cause vision loss and optic nerve damage. Closed angle, open angle, and normal tension glaucoma are the three kinds of glaucoma. The most prevalent type of glaucoma is open angle glaucoma, often known as wide angle glaucoma. Glaucoma is defined by an increase in intraocular pressure that results in optic nerve damage. Optic nerve dysfunction can result in permanent vision loss. Glaucoma, along with other illness conditions such as diabetes, is more common in the elderly population. Family history, obesity, high blood pressure, diabetes, increased eye pressure, migraines, and other conditions are all risk factors for glaucoma. Loss of peripheral vision, eye redness, eye pain, and limited vision are all symptoms of glaucoma.
Open angle glaucoma is painless and progresses progressively over time. Closed angle glaucoma, on the other hand, can develop suddenly. Eye pain, blurred vision, dilated pupils, and redness is all symptoms of this rapid occurrence. Topical eye drops from drug classes such as beta blockers, prostaglandins, carbonic anhydrase inhibitors, cholinergic medicines, alpha agonists, and combination therapy are used to treat open angle glaucoma. Topical eye drops might be used as a substitute for surgery or to postpone it. During the forecast period, the global open angle glaucoma market is expected to rise due to rising knowledge regarding the early identification of glaucoma and economical treatment choices. The market is being driven by an increase in the senior population, a rise in the diabetic population, increased awareness and cheap costs, new creative medicine combinations, and an increase in the number of myopia cases.
To Request a Sample of our Report on Open Angle Glaucoma Market: https://www.omrglobal.com/request-sample/open-angle-glaucoma-market
Market Coverage
- The market number available for – 2022-2030
- Base year- 2022
- Forecast period- 2023-2030
- Segment Covered
- Regions Covered- Globally
Competitive Landscape: Pfizer Inc., AstraZeneca, Merck & Co., Inc., Sanofi US, among others.
A full Report of Open Angle Glaucoma Market is Available @ https://www.omrglobal.com/industry-reports/open-angle-glaucoma-market
Open Angle Glaucoma Market by Segment
By Drug Class
- Beta Blockers
- Prostaglandins
- Carbonic Anhydrase Inhibitor
- Cholinergic Drugs
- Alpha Agonist
- Combined Medication
By Distribution Channel
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Open Angle Glaucoma Market by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/open-angle-glaucoma-market
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offer Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404